These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9001825)

  • 21. [Anti-HIV-1 effect of compound K3 from flower of Japanese pagoda tree in vitro].
    Zhang GH; Zheng YT
    Zhong Yao Cai; 2006 Apr; 29(4):355-8. PubMed ID: 16913492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chloroquine exerts an additive in vitro anti-HIV type 1 effect when associated with didanosine and hydroxyurea.
    Boelaert JR; Sperber K; Piette J
    AIDS Res Hum Retroviruses; 1999 Sep; 15(14):1241-7. PubMed ID: 10505672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of human immunodeficiency virus replication by RD6-Y664, a novel benzylhydroxylamine derivative.
    Okamoto M; Fujiwara M; Kodama E; Yamamoto O; Shigeta S; Mitsuya H; Konno K; Yokota T; Baba M
    Antivir Chem Chemother; 1999 Mar; 10(2):71-7. PubMed ID: 10335401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistant strains.
    Goudsmit J; Weverling GJ; van der Hoek L; de Ronde A; Miedema F; Coutinho RA; Lange JM; Boerlijst MC
    AIDS; 2001 Nov; 15(17):2293-301. PubMed ID: 11698703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cystamine inhibits HIV type 1 replication in cells of monocyte/macrophage and T cell lineages.
    Ho WZ; Zhu XH; Song L; Lee HR; Cutilli JR; Douglas SD
    AIDS Res Hum Retroviruses; 1995 Apr; 11(4):451-9. PubMed ID: 7632461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy.
    Zhu T; Muthui D; Holte S; Nickle D; Feng F; Brodie S; Hwangbo Y; Mullins JI; Corey L
    J Virol; 2002 Jan; 76(2):707-16. PubMed ID: 11752161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell specific uptake of antiretroviral drugs: AZT coupled to LDL inhibits HIV replication in human macrophages.
    Mankertz J; von Baeyer H; Rokos K; Nündel M; Pauli G; Riedel E
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):85-8. PubMed ID: 7757316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-HIV effects of chloroquine: mechanisms of inhibition and spectrum of activity.
    Savarino A; Gennero L; Chen HC; Serrano D; Malavasi F; Boelaert JR; Sperber K
    AIDS; 2001 Nov; 15(17):2221-9. PubMed ID: 11698694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxychloroquine induced lung cancer suppression by enhancing chemo-sensitization and promoting the transition of M2-TAMs to M1-like macrophages.
    Li Y; Cao F; Li M; Li P; Yu Y; Xiang L; Xu T; Lei J; Tai YY; Zhu J; Yang B; Jiang Y; Zhang X; Duo L; Chen P; Yu X
    J Exp Clin Cancer Res; 2018 Oct; 37(1):259. PubMed ID: 30373678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of the early phase of HIV replication by an isothiazolone, PD 161374.
    Sharmeen L; McQuade T; Heldsinger A; Gogliotti R; Domagala J; Gracheck S
    Antiviral Res; 2001 Feb; 49(2):101-14. PubMed ID: 11248362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro anti-HIV activity of oleanolic acid on infected human mononuclear cells.
    Mengoni F; Lichtner M; Battinelli L; Marzi M; Mastroianni CM; Vullo V; Mazzanti G
    Planta Med; 2002 Feb; 68(2):111-4. PubMed ID: 11859458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tuftsin-AZT conjugate: potential macrophage targeting for AIDS therapy.
    Fridkin M; Tsubery H; Tzehoval E; Vonsover A; Biondi L; Filira F; Rocchi R
    J Pept Sci; 2005 Jan; 11(1):37-44. PubMed ID: 15635725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired rescue of chain-terminated DNA synthesis associated with the L74V mutation in human immunodeficiency virus type 1 reverse transcriptase.
    Frankel FA; Marchand B; Turner D; Götte M; Wainberg MA
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2657-64. PubMed ID: 15980333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of human immunodeficiency virus type 1 infection in vitro by combination of delavirdine, zidovudine and didanosine.
    Chong KT; Pagano PJ
    Antiviral Res; 1997 Mar; 34(1):51-63. PubMed ID: 9107385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors.
    Savarino A; Lucia MB; Rastrelli E; Rutella S; Golotta C; Morra E; Tamburrini E; Perno CF; Boelaert JR; Sperber K; Cauda R
    J Acquir Immune Defic Syndr; 2004 Mar; 35(3):223-32. PubMed ID: 15076236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The additive in vitro anti-HIV-1 effect of chloroquine, when combined with zidovudine and hydroxyurea.
    Boelaert JR; Sperber K; Piette J
    Biochem Pharmacol; 2001 Jun; 61(12):1531-5. PubMed ID: 11377382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulatory effect of N-acetyl-L-cysteine on the HIV-1 multiplication in chronically and acutely infected cell lines.
    Pani A; Marongiu ME; La Colla P
    Antiviral Res; 1993 Sep; 22(1):31-43. PubMed ID: 8250542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to zidovudine during gestation or postnatally and treated with didanosine or zidovudine in the first three months of life.
    Kovacs A; Cowles MK; Britto P; Capparelli E; Fowler MG; Moye J; McIntosh K; Rathore MH; Pitt J; Husson RN
    Pediatr Infect Dis J; 2005 Jun; 24(6):503-9. PubMed ID: 15933559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment).
    Joshi P; Prasad VR
    J Virol; 2002 Jul; 76(13):6545-57. PubMed ID: 12050367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-tat Hutat2:Fc mediated protection against tat-induced neurotoxicity and HIV-1 replication in human monocyte-derived macrophages.
    Kang W; Marasco WA; Tong HI; Byron MM; Wu C; Shi Y; Sun S; Sun Y; Lu Y
    J Neuroinflammation; 2014 Nov; 11():195. PubMed ID: 25416164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.